Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP03 in Chronic Obstructive Pulmonary Disease (COPD)
NCT00219648Phase 2Unknown
- Sponsor
- PharmaEngine, Inc.
- Start
- Sep 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PEP03 in chronic obstructive pulmonary disease (COPD), sponsored by PharmaEngine, Inc.. Status: unknown.
02
Drugs
PEP03
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00219648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219648.